Liver Cirrhosis: all 1,668 studies
Page 14 of 17. Open to participants first (360), then studies with results posted, then the rest; newest registration first within each.
- Hepatic Fibrosis Non-invasive Methods QuestionnaireCompletedNCT02132351
- Telomeres Parameters in CirrhosisStatus unknownNCT02131831
- Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver TransplantationCompletedNCT02125071
- Development of Kinetic Biomarkers of Liver Fibrosis Measuring NAFLDStatus unknownNCT02124577
- Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial PeritonitisStatus unknownNCT02120196Phase 3
- TIPS Combined With Variceal Embolization for the Prevention of Variceal Rebleeding in Patients With CirrhosisCompletedNCT02119988Not applicable
- Rifaximin Predicts the Complications of Decompensated CirrhosisStatus unknownNCT02074280Phase 4
- Zinc Supplementation in Alcoholic CirrhosisCompletedNCT02072746Not applicable
- Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With CirrhosisCompletedNCT02069457
- Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Except for Liver CirrhosisCompletedNCT02068339Phase 3
- Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern AfricaCompletedNCT02060162
- Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRSWithdrawnNCT02048969Phase 1/2
- Renal Function Determination in Patients With Liver CirrhosisCompletedNCT02047240
- Noninvasive Staging of Liver Fibrosis: MR vs UltrasoundCompletedNCT02044523
- Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liver BiopsyCompletedNCT02041780Not applicable
- Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLDCompletedNCT02031913
- Phase 2 Study of NGM282 in Patients With Primary Biliary CirrhosisCompletedNCT02026401Phase 2
- A New Screening Strategy for VaricesCompletedNCT02024347
- Branched Chain Aminoacid Supplementation in Patients With Liver CirrhosisCompletedNCT02023229Phase 4
- Changes in Body Composition and Nutritional Status in Patients Undergoing Liver TransplantationStatus unknownNCT02023190
- Body Composition Analysis in Cirrhotic Undergoing ParacentesisStatus unknownNCT02022150
- Fructans, Lactitol and Lactose in Minimal Hepatic EncephalopathyCompletedNCT02022137Not applicable
- Influence of Probiotics Administration Before Liver Resection in Liver DiseaseCompletedNCT02021253Not applicable
- Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic EncephalopathyCompletedNCT02019784Phase 4
- Prospective Observational Study of Disease Progression in Chronic Hepatitis CActive, not recruitingNCT02011932
- Liver Fibrosis in Sickle Cell DiseaseCompletedNCT02007746
- Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With CirrhosisStatus unknownNCT01992978Not applicable
- Non-invasive Biomarkers of Fibrosis in Pediatric Liver DiseasesCompletedNCT01988753
- Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B CirrhosisStatus unknownNCT01987791
- Usefulness of Multi-parametric, Quantitative MR Imaging for Staging of Hepatic Fibrosis in the Patients With Chronic HepatitisStatus unknownNCT01981421
- Dynamic Preload Parameters During Liver TransplantationStatus unknownNCT01971333
- A Clinical Evaluation on Traditional Chinese Medicine Diagnosis and Treatment Program Blocking and Reversing Hepatitis B-related Liver Fibrosis - a Randomized, Controlled, Double-blind, Multi-center Clinical TrialStatus unknownNCT01965418Phase 4
- Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive ParametersCompletedNCT01962155
- Effects of Aerobic Training on Exercise Capacity in Patients With Advanced Cirrhosis 2CompletedNCT01960127Not applicable
- The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV TherapyStatus unknownNCT01957618
- Study of High-Dose Oral Vitamin D for the Prevention of Liver CancerWithdrawnNCT01956864Phase 1
- A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With CirrhosisTerminatedNCT01954524Phase 1
- Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In CirrhosisTerminatedNCT01951209Not applicable
- Real Time Elastography in Liver FibrosisStatus unknownNCT01948687
- Optimized Treatment and Regression of HBV-induced Compensated Liver CirrhosisCompletedNCT01943617Phase 4
- Boramae Hospital Liver Cirrhosis Patient Cohort StudyCompletedNCT01943318
- Umbilical Cord Blood Mononuclear Cells Therapy in Liver CirrhosisStatus unknownNCT01942915Phase 1
- Optimized Treatment and Regression of HBV-induced Early CirrhosisCompletedNCT01938820Phase 4
- Optimized Treatment and Regression of HBV-induced Liver FibrosisCompletedNCT01938781Phase 4
- Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBVCompletedNCT01935817Phase 3
- Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic SteatohepatitisCompletedNCT01934777Phase 3
- LIVER FIBROSIS PREVALENCE IN FRANCEStatus unknownNCT01927133
- Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)WithdrawnNCT01923376Not applicable
- Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver CirrhosisCompletedNCT01904409Phase 2
- A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.CompletedNCT01902511Not applicable
- Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic PatientsStatus unknownNCT01897051Phase 2/3
- Magnesium in Liver CirrhosisStatus unknownNCT01894867Phase 4
- Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic CirrhosisCompletedNCT01884415Phase 3
- A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver CirrhosisStatus unknownNCT01877759Phase 1/2
- REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)CompletedNCT01875081Phase 2
- Validation of BIVA for Nutritional Assessment in Cirrhotic PatientsCompletedNCT01872793
- Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver FailureCompletedNCT01872767
- Validation of Child-Turcotte-Pugh-Kumar (CTPK) Score in Predicting Short Term Mortality in Patients With Liver CirrhosisStatus unknownNCT01863121
- Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary CirrhosisCompletedNCT01857284Phase 3
- Efficacy and Safety of Tolvaptan in Cirrhotic Patients With HyponatremiaCompletedNCT01850940
- Surveillance Study for HCC by Combining Biomarkers With Imaging (ALDUS)Status unknownNCT01846949
- Quality of Life and Nutritional Improvements in Cirrhotic PatientsTerminatedNCT01842113Phase 4
- Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care UnitCompletedNCT01836224Not applicable
- The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) StudyWithdrawnNCT01831037
- Stratification of Patients With Chronic Liver Disease Using Multi Spectral CTCompletedNCT01825213
- Is Access to Liver Transplantation Similar in Alcoholic or Not Patients?CompletedNCT01820819
- Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in CirrhosisStatus unknownNCT01820026Phase 4
- Liver Fibrosis in Alpha-1 Antitrypsin Deficiency (Liver AATD)CompletedNCT01810458
- Evaluating Ultrasound, Elastometry, Minilaparoscopy and Histology for the Diagnosis of Compensated Liver Cirrhosis.Status unknownNCT01807013
- Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.CompletedNCT01804829Phase 3
- Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side EffectsWithdrawnNCT01801228Phase 2
- Effects of Aerobic Training on Exercise Capacity in Patients With CirrhosisCompletedNCT01799785Not applicable
- Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled TrialStatus unknownNCT01799486Phase 4
- Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic PatientsCompletedNCT01798173Not applicable
- Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.CompletedNCT01789008Not applicable
- Screening for Liver Fibrosis by Using Non-invasive Methods ( Fibro Scan) in Patients With Elevated Liver EnzymesStatus unknownNCT01784484
- Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate DisodiumStatus unknownNCT01783314Phase 4
- Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time MeasurementCompletedNCT01773538Not applicable
- Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With CirrhosisCompletedNCT01769040Phase 4
- Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver TransplantCompletedNCT01762748Phase 2
- HVPG for Rebleeding Risk StratificationCompletedNCT01751191
- An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1CompletedNCT01750216
- The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver CirrhosisStatus unknownNCT01741090Phase 2
- Administration of Probiotics in Cirrhotic Patients Listed for Liver TransplantationCompletedNCT01735591Not applicable
- Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver CirrhosisStatus unknownNCT01728727Phase 1/2
- Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver CirrhosisStatus unknownNCT01728688Phase 1/2
- Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver CirrhosisStatus unknownNCT01724697Phase 1/2
- L-ornithine L-aspartate in Overt Hepatic EncephalopathyCompletedNCT01722578Phase 4
- Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver CirrhosisStatus unknownNCT01720238
- Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis PatientsStatus unknownNCT01718587Phase 1/2
- Subclinical Myocardial Dysfunction in Patients With Hepatic CirrhosisCompletedNCT01713478Not applicable
- Biomarkers for the Prognosis of Decompensated Alcoholic Liver DiseaseCompletedNCT01701687
- VSL#3 and Spontaneous Bacterial PeritonitisTerminatedNCT01701297Phase 2
- Telbivudine Renoprotective Effect in Patients With HBV-related Liver CirrhosisStatus unknownNCT01693679Phase 4
- Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic LiverTerminatedNCT01686880Phase 2
- Effect of VSL#3 (Original De Simone Formulation) on Cognitive Function, Risk of Falls and Quality of Life in Patients With CirrhosisCompletedNCT01686698Phase 4
- Metoprolol Succinate in Cardiac Remodeling Related to CirrhosisCompletedNCT01676285Phase 3
- An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C InfectionCompletedNCT01671046
- Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary CirrhosisStatus unknownNCT01662973Phase 1/2
- Genetic Studies of Non-Alcoholic Fatty Liver DiseaseTerminatedNCT01629095